JP5462191B2 - 中鎖ジカルボン酸、その誘導体及び代謝異常 - Google Patents
中鎖ジカルボン酸、その誘導体及び代謝異常 Download PDFInfo
- Publication number
- JP5462191B2 JP5462191B2 JP2010550155A JP2010550155A JP5462191B2 JP 5462191 B2 JP5462191 B2 JP 5462191B2 JP 2010550155 A JP2010550155 A JP 2010550155A JP 2010550155 A JP2010550155 A JP 2010550155A JP 5462191 B2 JP5462191 B2 JP 5462191B2
- Authority
- JP
- Japan
- Prior art keywords
- use according
- acid
- product
- glucose
- sebacic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Ophthalmology & Optometry (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Description
C10非含有群(対照群):CHO50%、タンパク質15%及び脂質35%プラス水
C10 23g群:CHO50%、タンパク質15%及びC10DA35%(23g)プラス水
C10 10g群:CHO50%、タンパク質15%及び脂質35%プラスC10 10gプラス水
・血糖症曲線下面積(AUC)について、C10DA10gの食事による有意な減少(−17%)及びC10DA23gの食事による有意な減少(−16%)
・インスリン分泌率について、C10DA23gの食事による有意な減少(−35%)
・内因性グルコース産生について、C10DA10gの食事による有意な減少(−10%)及びC10DA23gの食事による有意な減少(−9%)
・糖新生(%)について、C10DA10gの食事による有意な減少(−2.1%)及びC10DA23gの食事による有意な減少(−2.3%)
・グルコースクリアランスについて、C10DA10gの食事による有意な増加(+12.6%)及びC10DA23gの食事による有意な増加(+8.2%)
を示した。
Claims (11)
- 2型糖尿病を治療する又は予防する製品を調製するための、セバシン酸(C10)及び/又はその誘導体を含む組成物の使用であって、
前記製品が医薬品であり、
前記誘導体が、セバシン酸(C10)の塩の形態、及びセバシン酸(C10)のエステルからなる群より選択される、使用。 - 製品が、タンパク質源、炭水化物源及び/又は脂質源をさらに含み、経口的に又は経腸的に適用するためのものである、請求項1に記載の使用。
- 組成物がさらに、アジピン酸(C6)、スベリン酸(C8)、ドデカン二酸(C12)、及びそれらの混合物からなる群より選択される中鎖ジカルボン酸を含む、請求項1または2に記載の使用。
- 前記セバシン酸(C10)の塩の形態が、ナトリウム、カリウム、カルシウム、マグネシウム又はアミノ酸塩であり、前記セバシン酸(C10)のエステルが、グリセリンエステル又はエタノールエステルである、請求項1〜3のいずれか一項に記載の使用。
- 少なくとも1つのセバシン酸(C10)又はその誘導体が製品中に1日用量当たり1g〜50gの量である、請求項1〜4のいずれか一項に記載の使用。
- 製品が少なくとも1種の食品級の細菌を含む、請求項1〜5のいずれか一項に記載の使用。
- 食品級の細菌がプロバイオティクスである、請求項6に記載の使用。
- プロバイオティクスが、ビフィドバクテリウム属、ラクトバシラス属、ストレプトコッカス属及びサッカロミセス属又はそれらの混合物からなる群より選択されることを特徴とする請求項7に記載の使用。
- 製品が少なくとも1つのプレバイオティクスを含有し、前記プレバイオティクスは、ガラクトース、マンノース、大豆及び/又はイヌリンを含有するオリゴ糖、食物繊維、或いはそれらの混合物からなる群より選択される、請求項1〜8のいずれか一項に記載の使用。
- 製品が前糖尿病の又は2型糖尿病の対象に投与される、請求項1〜9のいずれか一項に記載の使用。
- 製品が食中又は食後に投与される、請求項1〜10のいずれか一項に記載の使用。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP20080152549 EP2100604B1 (en) | 2008-03-10 | 2008-03-10 | Medium chain dicarboxylic acids and their derivates and metabolic disorders |
EP08152549.5 | 2008-03-10 | ||
PCT/EP2009/052721 WO2009112455A1 (en) | 2008-03-10 | 2009-03-09 | Medium chain dicarboxylic acids, their derivates and metabolic disorders |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2011513458A JP2011513458A (ja) | 2011-04-28 |
JP5462191B2 true JP5462191B2 (ja) | 2014-04-02 |
Family
ID=39688777
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2010550155A Expired - Fee Related JP5462191B2 (ja) | 2008-03-10 | 2009-03-09 | 中鎖ジカルボン酸、その誘導体及び代謝異常 |
Country Status (16)
Country | Link |
---|---|
US (2) | US8962689B2 (ja) |
EP (1) | EP2100604B1 (ja) |
JP (1) | JP5462191B2 (ja) |
CN (2) | CN105456242A (ja) |
AR (1) | AR070869A1 (ja) |
AU (1) | AU2009224732B2 (ja) |
BR (1) | BRPI0909835A2 (ja) |
CA (1) | CA2718007C (ja) |
DK (1) | DK2100604T3 (ja) |
ES (1) | ES2390620T3 (ja) |
MX (1) | MX2010009883A (ja) |
PT (1) | PT2100604E (ja) |
RU (1) | RU2445955C1 (ja) |
TW (1) | TW200944196A (ja) |
WO (1) | WO2009112455A1 (ja) |
ZA (1) | ZA201007212B (ja) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2100604B1 (en) | 2008-03-10 | 2012-07-04 | Nestec S.A. | Medium chain dicarboxylic acids and their derivates and metabolic disorders |
EP2397145A1 (en) * | 2010-06-18 | 2011-12-21 | Nestec S.A. | L. johnsonii La1, B. longum NCC2705 and immune disorders |
EP2510932A1 (en) * | 2011-04-15 | 2012-10-17 | Nestec S.A. | Lactobacillus paracasei NCC2461 (ST11) for use by perinatal maternal administration in the reduction and prevention of allergies in progeny |
KR101101808B1 (ko) * | 2011-06-01 | 2012-01-05 | 연세대학교 산학협력단 | 아디픽산의 신규한 용도 |
US9820504B2 (en) | 2013-03-08 | 2017-11-21 | Axiom Foods, Inc. | Rice protein supplement and methods of use thereof |
CA2901469A1 (en) | 2013-03-08 | 2014-09-12 | Axiom Foods, Inc. | Rice protein supplements |
JP6959246B2 (ja) | 2016-03-04 | 2021-11-02 | ユニバーシティ オブ ピッツバーグ−オブ ザ コモンウェルス システム オブ ハイヤー エデュケーションUniversity Of Pittsburgh Of The Commonwealth System Of Higher Education | 治療に有効な量のジカルボン酸化合物を使用した、病気の予防、治療及び治癒 |
EP4085907A1 (en) * | 2016-04-20 | 2022-11-09 | New Frontier Labs, LLC | Diethyl azelate in the treatment of type 2 diabetes |
EP3634155A4 (en) | 2017-05-12 | 2021-02-17 | Axiom Foods Inc. | RICE PRODUCTS AND SYSTEMS AND PROCESSES FOR THEIR PRODUCTION |
CN111526723A (zh) * | 2017-12-22 | 2020-08-11 | 杰迈尔有限公司 | 二元羧酸的新用途和应用 |
CN109200043A (zh) * | 2018-10-23 | 2019-01-15 | 华南农业大学 | 二羧酸(盐)在降低脂肪沉积和预防肥胖方面的应用 |
US20220015404A1 (en) * | 2018-12-06 | 2022-01-20 | International Flavors & Fragrances Inc. | Traumatic acid compositions and methods for taste modulation |
ES2962815T3 (es) * | 2018-12-06 | 2024-03-21 | Int Flavors & Fragrances Inc | Composiciones de ácido sebácico y métodos para la modulación del sabor |
BR112021010407A2 (pt) * | 2018-12-06 | 2021-08-24 | International Flavors & Fragrances Inc. | Artigo de consumo, e, métodos para realçar a doçura ou sensação bucal de um artigo de consumo e para mascarar um sabor proteináceo desagradável de um artigo de consumo |
CN110205261B (zh) * | 2019-05-10 | 2020-08-04 | 湖南菲勒生物技术有限公司 | 一种母乳来源罗伊氏乳杆菌降脂及调节脂代谢节律的应用 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2982658A (en) * | 1957-04-11 | 1961-05-02 | Wasco Chemical Co Inc | Method for coating articles of food and composition therefor |
US3360375A (en) * | 1967-05-16 | 1967-12-26 | Paniplus Company | Yeast leavened bakery products and shortening compositions |
JPS61130205A (ja) * | 1984-11-30 | 1986-06-18 | Sunstar Inc | アスコルビン酸を安定に配合した水系組成物 |
JPS61171417A (ja) * | 1985-01-23 | 1986-08-02 | Wakunaga Seiyaku Kk | 抗糖尿病剤 |
IT1232161B (it) | 1989-07-31 | 1992-01-25 | Sigma Tau Ind Farmaceuti | Uso dell'acido sebacico e di suoi derivati nell'alimentazione enterale e parentaerale e composizioni farmaceutiche contenenti tali composti |
US5219604A (en) * | 1991-02-13 | 1993-06-15 | Nabisco, Inc. | Use of ester-bridged side chains to suppress caloric availability of fat compounds |
EP0861598A1 (en) * | 1997-02-19 | 1998-09-02 | Rhone-Poulenc Nutrition Animale | Dicarboxylic acids as an animal feed ingredient |
JPH10327805A (ja) | 1997-06-02 | 1998-12-15 | Yasuma Kk | マグネシウム含有食品組成物 |
US6410305B1 (en) * | 1997-08-04 | 2002-06-25 | Biosun Systems Corporation | Treatment of animal waste |
US6432448B1 (en) * | 1999-02-08 | 2002-08-13 | Fmc Corporation | Edible coating composition |
SE523771C2 (sv) * | 1999-05-21 | 2004-05-18 | Probi Ab | Sportdryck innehållande mikronäringsämnen i kombination med levande laktobaciller |
JP4580542B2 (ja) | 2000-05-17 | 2010-11-17 | 株式會社バイオニア | 肥満又は糖尿病治療用微生物及びその微生物を含む医薬組成物 |
ES2264482T3 (es) * | 2001-05-15 | 2007-01-01 | F. Hoffmann-La Roche Ag | Derivados de oxazol sustituidos por acido carboxilico para uso como activadores de ppar-alfa y gamma en el tratamiento de diabetes. |
MY135783A (en) * | 2001-09-07 | 2008-06-30 | Meiji Dairies Corp | Nutritional composition for controlling blood sugar level |
US20050266069A1 (en) * | 2002-09-06 | 2005-12-01 | Simmons Donald L | Stable probiotic microsphere compositions and their methods of preparation |
FR2844453B1 (fr) * | 2002-09-13 | 2006-05-19 | Agronomique Inst Nat Rech | Utilisation de pre-biotiques pour la prevention de l'installation du diabete de type ii |
JP2008501027A (ja) * | 2004-05-28 | 2008-01-17 | メルク エンド カムパニー インコーポレーテッド | 抗糖尿病活性をもつベンゾ尿素 |
WO2006052134A2 (en) * | 2004-11-12 | 2006-05-18 | N.V. Nutricia | Food composition comprising a protein- and a lipid fraction for rapidly attenuating inflammatory responses |
CN100364533C (zh) * | 2005-04-19 | 2008-01-30 | 北京正大绿洲医药科技有限公司 | 盐酸吡格列酮滴丸及其制备方法 |
EP2100604B1 (en) | 2008-03-10 | 2012-07-04 | Nestec S.A. | Medium chain dicarboxylic acids and their derivates and metabolic disorders |
-
2008
- 2008-03-10 EP EP20080152549 patent/EP2100604B1/en not_active Not-in-force
- 2008-03-10 PT PT08152549T patent/PT2100604E/pt unknown
- 2008-03-10 DK DK08152549T patent/DK2100604T3/da active
- 2008-03-10 ES ES08152549T patent/ES2390620T3/es active Active
-
2009
- 2009-03-09 MX MX2010009883A patent/MX2010009883A/es active IP Right Grant
- 2009-03-09 WO PCT/EP2009/052721 patent/WO2009112455A1/en active Application Filing
- 2009-03-09 CN CN201510680983.2A patent/CN105456242A/zh active Pending
- 2009-03-09 RU RU2010141525/15A patent/RU2445955C1/ru not_active IP Right Cessation
- 2009-03-09 CN CN2009801067665A patent/CN101959512A/zh active Pending
- 2009-03-09 US US12/921,404 patent/US8962689B2/en not_active Expired - Fee Related
- 2009-03-09 BR BRPI0909835A patent/BRPI0909835A2/pt not_active IP Right Cessation
- 2009-03-09 JP JP2010550155A patent/JP5462191B2/ja not_active Expired - Fee Related
- 2009-03-09 CA CA2718007A patent/CA2718007C/en not_active Expired - Fee Related
- 2009-03-09 AU AU2009224732A patent/AU2009224732B2/en not_active Ceased
- 2009-03-10 AR ARP090100849 patent/AR070869A1/es unknown
- 2009-03-10 TW TW98107799A patent/TW200944196A/zh unknown
-
2010
- 2010-10-08 ZA ZA2010/07212A patent/ZA201007212B/en unknown
-
2015
- 2015-01-09 US US14/593,609 patent/US20150125426A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CN105456242A (zh) | 2016-04-06 |
DK2100604T3 (da) | 2012-07-23 |
TW200944196A (en) | 2009-11-01 |
US8962689B2 (en) | 2015-02-24 |
EP2100604B1 (en) | 2012-07-04 |
AR070869A1 (es) | 2010-05-12 |
BRPI0909835A2 (pt) | 2015-10-06 |
MX2010009883A (es) | 2010-10-08 |
CA2718007A1 (en) | 2009-09-17 |
AU2009224732A1 (en) | 2009-09-17 |
JP2011513458A (ja) | 2011-04-28 |
CA2718007C (en) | 2013-06-18 |
WO2009112455A1 (en) | 2009-09-17 |
AU2009224732B2 (en) | 2014-08-21 |
US20150125426A1 (en) | 2015-05-07 |
US20110002900A1 (en) | 2011-01-06 |
RU2445955C1 (ru) | 2012-03-27 |
ES2390620T3 (es) | 2012-11-14 |
PT2100604E (pt) | 2012-07-24 |
ZA201007212B (en) | 2012-03-28 |
CN101959512A (zh) | 2011-01-26 |
EP2100604A1 (en) | 2009-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5462191B2 (ja) | 中鎖ジカルボン酸、その誘導体及び代謝異常 | |
JP5497634B2 (ja) | 術前及び/又は術後環境におけるプロバイオティックス | |
EP3074020B1 (en) | Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants and young children | |
JP5438003B2 (ja) | ラクトバチルスラムノサス及び体重管理 | |
AU2009268209B2 (en) | A nutritional composition with free amino acids and structured lipids | |
EP2308498A1 (en) | Administration of Bifidobacterium breve during infancy to prevent inflammation later in life | |
CN114522175A (zh) | 用于预防或治疗婴儿和幼儿的坏死性小肠结肠炎的组合物 | |
JP2006520335A (ja) | 脂肪酸とアミノ酸を含有する組成物 | |
MX2011000737A (es) | Probioticos para aumentar la secrecion de iga en infantes nacidos a traves de operacion cesarea. | |
JP2021504420A (ja) | 微生物叢調節のためのヒトミルクオリゴ糖およびその合成組成物 | |
JP2013506631A (ja) | ビフィドバクテリウム・ロンガムatccbaa−999(bl999)及び体重コントロール | |
TW201225858A (en) | Array of complementary infant/young child nutritional compositions | |
CN110650635A (zh) | 出于健康目的而用于婴儿或幼儿的hmo共混物 | |
WO2023205762A1 (en) | Methods and compositions for slowing diabetes development or reducing a risk of diabetes | |
WO2023099750A1 (en) | Nutritional composition for improving infant microbiota | |
WO2022129556A1 (en) | Compositions for use in promoting accelerated butyrate production in young children | |
CN117859893A (zh) | 一种健康膳食补充剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20121127 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130227 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20130507 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130909 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20131028 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20131119 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20131209 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20140114 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20140116 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |